A D S Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve Board meeting of ADS Diagnostic ....
Awaiting price reaction for this filing.
A D S Diagnostics Ltd has informed BSE that its Board of Directors will meet on Tuesday, 12th August 2025 at the registered office in New Delhi. The main item on the agenda is to consider and approve the Unaudited Financial Results for the quarter ended 30th June 2025 (Q1 FY26). The notice also allows for any other business items that the Chairman may bring up. This is filed under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. No financial numbers or results have been disclosed in this filing — only the intimation of the upcoming meeting.
This is a routine pre-results intimation and carries no immediate material impact on the stock. Shareholders should watch for the actual Q1 FY26 results announcement after 12th August 2025 for any meaningful insight into revenue, margins, and overall business performance.